CytomX Therapeutics Announces Third Quarter 2018 Financial Results
Go back to CytomX Therapeutics Announces Third Quarter 2018 Financial Results| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.27 -0.08 (2.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.35 | 52 Week High | $24.68 | |||
| Open | $3.38 | 52 Week Low | $9.10 | |||
| Day High | $3.41 | P/E | N/A | |||
| Day Low | $3.23 | EPS | $0.00 | |||
| Volume | 992,590 | |||||

